ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

Clinical trials for ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) explained in plain language.

Never miss a new study

Get alerted when new ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) trials appear

Sign up with your email to follow new studies for ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough blood cancers: stronger chemo before transplant

Disease control Ongoing

This study is testing if adding a drug called Romidepsin to standard chemotherapy (CHOEP) makes treatment more effective for young adults with aggressive types of T-cell lymphoma. The goal is to better control the cancer before patients receive a stem cell transplant. The trial f…

Matched conditions: ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

Phase: PHASE1, PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

Get alerted when new ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) trials appear

New hope for tough blood cancers: stronger chemo before transplant